HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

For Consumer Health Industry, Pandemic-Driven Buying Reveals Signs For Sustaining Sales Growth

Executive Summary

"It's a great industry to be in with it being pandemic proof," says Natural Marketing Institute managing partner Steve French. "Consumers really want one-stop shopping in this situation. They want stores they can get into and get out of it," says IRI health care executive Kristin Hornberger.

You may also be interested in...



Gummy Format And Immunity Health Have Legs As Sales Drivers For US Supplement Market

“It's not that gummies have taken over the entire pill format,” says nutritional product business consultant Thomas Aarps. “But the trend is obviously to gummies.” Meanwhile, multiple COVID variants keep consumers attuned to immunity health. “Immunity is big, it's going to be big.”

Pharmavite Monthly Survey Shows Supplement Use In US Continues Growing During Pandemic

Teachers are among the 500 to 700 consumers responding to monthly nationwide survey on nutritional supplement usage Pharmavite started in April 2020 as novel coronavirus pandemic began widespread impact across US, says chief marketing officer Rhonda Hoffman.

US Herbal Supplement Sales Pass $10Bn For First Time In 2020 As Consumers Hunt Immunity Health

Report by American Botanical Council from research by Nutrition Business Journal and SPINS shows sales of supplements with herbal and/or fungal ingredients increased a record 17.3% from 2019, the segment's first double-digit growth in at least 20 years.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS149938

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel